GEN vs LAB · P/E 17, rev $5.00B vs rev $174.4M
Gen Digital Inc. (GEN) versus Standard Biotools Inc (LAB) — a side-by-side from cached financials, not a winner call.
Gen Digital Inc. (GEN) is a software - infrastructure company listed on US.
Standard Biotools Inc (LAB) is a medical devices company listed on NASDAQ.
Latest reported GEN revenue for 2026-04-03 was $5.00B. Net income was $973.0M. Revenue was up 27.1% from 2025-03-28 to 2026-04-03. GEN currently screens at market cap $15.83B and trailing P/E 16.7.
Latest reported LAB revenue for 2024-12-31 was $174.4M. Net income was -$138.9M. Revenue was up 64.0% from 2023-12-31 to 2024-12-31. LAB currently screens at market cap $317.1M.
GEN currently screens at market cap $15.83B and trailing P/E 16.7. LAB currently screens at market cap $317.1M.
Not investment advice. Open the GEN and LAB stock pages for the full models.
Not investment advice.